ENDECE, LLC.

ENDECE, LLC (ENDECE) is dedicated to discovering and developing small molecules that provide an improved quality of life for patients diagnosed with debilitating disorders with few therapeutic options. ENDECE’s pipeline of products is designed to treat cancers with low five-year survival rates, neurodegenerative autoimmune diseases (e.g. MS), and pain.

Read More

Media & Press

 

 

Media & Press

Structurally similar estradiol analogs uniquely alter the regulation of intracellular signaling pathways

Read More

ENDECE Neural to Present Findings at 2013 Biotech Showcase on NDC-1308 which Induces Remyelination of Demyelinated Axons.

Read More

Read More